A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

被引：5
|
作者：
Schmucker, Christine [1 ]
Antes, Gerd [1 ]
Lelgemann, Monika [2 ]
机构：
[1] Univ Med Ctr Freiburg, German Cochrane Ctr, Freiburg, Germany
[2] Univ Bremen, Hlth Technol Assessment Ctr, Bremen, Germany
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2010年 / 248卷 / 03期
关键词：
Age-related macular degeneration; Bevacizumab; Efficacy; Safety; VERTEPORFIN PHOTODYNAMIC THERAPY; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB; SAFETY;
D O I：
10.1007/s00417-009-1249-5
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：451 / 452
页数：2
相关论文
共 50 条
  • [1] A systematic review on the effect of bevacizumab in exudative age-related macular degeneration
    Jan S. A. G. Schouten
    Ellen C. La Heij
    Carroll A. B. Webers
    Igor J. Lundqvist
    Fred Hendrikse
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247
  • [2] A systematic review on the effect of bevacizumab in exudative age-related macular degeneration
    Christine Schmucker
    Gerd Antes
    Monika Lelgemann
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 451 - 452
  • [3] A systematic review on the effect of bevacizumab in exudative age-related macular degeneration
    Schouten, Jan S. A. G.
    La Heij, Ellen C.
    Webers, Carroll A. B.
    Lundqvist, Igor J.
    Hendrikse, Fred
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (01) : 1 - 11
  • [4] Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration
    Jonas, Jost B.
    Libondi, Teodosio
    Golubkina, Lidia
    Spandau, Ulrich H.
    Schlichtenbrede, Frank
    Rensch, Florian
    ACTA OPHTHALMOLOGICA, 2010, 88 (06) : 630 - 634
  • [5] TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Forooghian, Farzin
    Cukras, Catherine
    Meyerle, Catherine B.
    Chew, Emily Y.
    Wong, Wai T.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 723 - 731
  • [6] Intravitreal Bevacizumab and Aflibercept for the Treatment of Exudative Age-Related Macular Degeneration
    Selid, Paul D.
    Jundt, Michael C.
    Fortney, Aaron C.
    Beal, James R.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (04): : 275 - 281
  • [7] Intravitreal Bevacizumab for Exudative Age-Related Macular Degeneration in Clinical Practice
    Jonas, Jost B.
    Tao, Yong
    Schlichtenbrede, Frank C.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (05) : 467 - 470
  • [8] A systematic review on the effect of bevacizumab in exudative age-related macular degeneration: a response to a letter to the editor by Schmucker et al.
    Schouten, Jan S. A. G.
    La Heij, Ellen C.
    Webers, Carroll A. B.
    Lundqvist, Igor J.
    Hendrikse, Fred
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (03) : 453 - 454
  • [9] A systematic review on the effect of bevacizumab in exudative age-related macular degeneration: a response to a letter to the editor by Schmucker et al.
    Jan S. A. G. Schouten
    Ellen C. La Heij
    Carroll A. B. Webers
    Igor J. Lundqvist
    Fred Hendrikse
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 453 - 454
  • [10] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    International Ophthalmology, 2010, 30 (3) : 261 - 266
12345